These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3142812)

  • 21. Benzodiazepines inhibit human platelet activation: comparison of the mechanism of antiplatelet actions of flurazepam and diazepam.
    Romstedt K; Huzoor-Akbar
    Thromb Res; 1985 May; 38(4):361-74. PubMed ID: 2990062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel inhibitory actions on platelet thromboxane and inositolphosphate formation by xanthones and their glycosides.
    Teng CM; Lin CN; Ko FN; Cheng KL; Huang TF
    Biochem Pharmacol; 1989 Nov; 38(21):3791-5. PubMed ID: 2512926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of platelet aggregation by a new agent, Ticlopidine.
    Ashida SI; Abiko Y
    Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of cobra venom phospholipase A2 on platelet aggregation in comparison with those produced by arachidonic acid and lysophophatidylcholine.
    Teng CM; Kuo YP; Lee LG; Ouyang C
    Thromb Res; 1986 Dec; 44(6):875-86. PubMed ID: 3099424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet hypersensitivity in cholesterol-fed rabbits: enhancement of thromboxane A2-dependent and thrombin-induced, thromboxane A2-independent platelet responses.
    Gross PL; Rand ML; Barrow DV; Packham MA
    Atherosclerosis; 1991 May; 88(1):77-86. PubMed ID: 1878012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of a polyoxyethylene detergent (Brij 58) on platelet aggregation, release and clotting activity.
    Barton PG
    Biochim Biophys Acta; 1978 Feb; 539(1):98-113. PubMed ID: 623796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyclic adenosine 3',5'-monophosphate inhibits the availability of arachidonate to prostaglandin synthetase in human platelet suspensions.
    Minkes M; Stanford N; Chi MM; Roth GJ; Raz A; Needleman P; Majerus PW
    J Clin Invest; 1977 Mar; 59(3):449-54. PubMed ID: 190267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathways responsible for platelet hypersensitivity in rats with diabetes. I. Streptozocin-induced diabetes.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    J Lab Clin Med; 1986 Feb; 107(2):148-53. PubMed ID: 3080538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of thromboxane A2.
    Ambler J; Birch J; Maguire ED; Wallis RB
    Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
    [No Abstract]   [Full Text] [Related]  

  • 30. Novel thienylacylhydrazone derivatives inhibit platelet aggregation through cyclic nucleotides modulation and thromboxane A2 synthesis inhibition.
    Brito FC; Kummerle AE; Lugnier C; Fraga CA; Barreiro EJ; Miranda AL
    Eur J Pharmacol; 2010 Jul; 638(1-3):5-12. PubMed ID: 20412790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enrichment of human platelet phospholipids with linoleic acid diminishes thromboxane release.
    Needleman SW; Spector AA; Hoak JC
    Prostaglandins; 1982 Nov; 24(5):607-22. PubMed ID: 6819602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of phospholipase C in platelet responses.
    Lapetina EG; Siess W
    Life Sci; 1983 Sep; 33(11):1011-8. PubMed ID: 6412009
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Platelet aggregation in the Asian elephant is not dependent on thromboxane B2 production.
    Gentry PA; Niemuller C; Ross ML; Liptrap RM
    Comp Biochem Physiol A Comp Physiol; 1989; 94(1):47-51. PubMed ID: 2571453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A platelet phospholipase inhibitor from the medicinal herb feverfew (Tanacetum parthenium).
    Makheja AN; Bailey JM
    Prostaglandins Leukot Med; 1982 Jun; 8(6):653-60. PubMed ID: 6810384
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
    Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of phospholipase inhibitor mepacrine on platelet aggregation, the platelet release reaction and fibrinogen binding to the platelet surface.
    Winocour PD; Kinlough-Rathbone RL; Mustard JF
    Thromb Haemost; 1981 Jun; 45(3):257-62. PubMed ID: 7281105
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of supplementation with unsaturated fatty acids on plasma and membrane lipid composition and platelet function in patients with cirrhosis and defective aggregation.
    Marra F; Riccardi D; Melani L; Spadoni S; Galli C; Fabrizio P; Tosti-Guerra C; Carloni V; Gentilini P; Laffi G
    J Hepatol; 1998 Apr; 28(4):654-61. PubMed ID: 9566835
    [TBL] [Abstract][Full Text] [Related]  

  • 38. XC 386: a new antiplatelet agent.
    Wang JP; Hsu MF; Tsai HY; Huang LJ; Teng CM
    Thromb Res; 1984 Oct; 36(2):113-22. PubMed ID: 6438827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hydrogen peroxide triggers activation of human platelets selectively exposed to nonaggregating concentrations of arachidonic acid and collagen.
    Pratico D; Iuliano L; Pulcinelli FM; Bonavita MS; Gazzaniga PP; Violi F
    J Lab Clin Med; 1992 Apr; 119(4):364-70. PubMed ID: 1583386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function.
    Rao GH; Radha E; White JG
    Biochem Biophys Res Commun; 1983 Dec; 117(2):549-55. PubMed ID: 6229254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.